FDA Approves New ALS Drug Despite Uncertain Data

FRIDAY, Sept. 30, 2022 – The U.S. Food and Drug Administration on Thursday gave its approval to a new drug for ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig's disease.
But approval of the drug, called Relyvrio, is bound to stir new...